European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 147, Issue 2 , Pages 161-165 , December 2009

Maternal pro-hepcidin at term correlates with cord blood pro-hepcidin at birth

  • Mari Ervasti

      Affiliations

    • Department of Clinical Chemistry and Hematology, Kuopio University, and Eastern Finland Laboratory Centre (ISLAB), Post box 1700, 70211 Kuopio, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358 44 7178716; fax: +358 17 173200.
    • ,
  • Ulla Sankilampi

      Affiliations

    • Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland
    • ,
  • Susanna Luukkonen

      Affiliations

    • Department of Clinical Chemistry and Hematology, Kuopio University, and Eastern Finland Laboratory Centre (ISLAB), Post box 1700, 70211 Kuopio, Finland
    • ,
  • Seppo Heinonen

      Affiliations

    • Department of Obstetrics and Gynecology, Kuopio University Hospital, Kuopio, Finland
    • ,
  • Kari Punnonen

      Affiliations

    • Department of Clinical Chemistry and Hematology, Kuopio University, and Eastern Finland Laboratory Centre (ISLAB), Post box 1700, 70211 Kuopio, Finland

Received 6 May 2009 ,Revised 11 August 2009 ,Accepted 18 August 2009.

References 

  1. O’Brien KO, Zavaleta N, Abrams SA, Caulfield LE. Maternal iron status influences iron transfer to the fetus during the third trimester of pregnancy. Am J Clin Nutr. 2003;77:924–930
  2. Martin ME, Nicolas G, Hetet G, Vaulont S, Grandchamp B, Beaumont C. Transferrin receptor 1 mRNA is downregulated in placenta of hepcidin transgenic embryos. FEBS Lett. 2004;574:187–191
  3. McArdle HJ, Andersen HS, Jones H, Gambling L. Copper and iron transport across the placenta: regulation and interactions. J Neuroendocrinol. 2008;20:427–431
  4. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093
  5. Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112:219–230
  6. De Domenico I, McVey , Ward D, et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell. 2007;18:2569–2578
  7. Krause A, Neitz S, Mägert H-J, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147–150
  8. Muehlenbachs A, Fried M, Lachowitzer J, Mutabingwa TK, Duffy PE. Genome-wide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection. J Immunol. 2007;179:557–565
  9. Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol. 2004;11:251–254
  10. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037–1044
  11. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811–7819
  12. Gehrke SG, Kulaksiz H, Herrmann T, et al. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood. 2003;102:371–376
  13. Millard KN, Frazer DM, Wilkins SJ, Anderson GJ. Changes in the expression of intestinal iron transport and hepatic regulatory molecules explain the enhanced iron absorption associated with pregnancy in the rat. Gut. 2004;53:655–660
  14. Gambling L, Danzeisen R, Gair S, et al. Effect of iron deficiency on placental transfer of iron and expression of iron transport proteins in vivo and in vitro. Biochem J. 2003;356:883–889
  15. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human hepcidin. Blood. 2008;112:4292–4297
  16. Grebenchtchikov N, Geurts-Moespot AJ, Kroot JJC, et al. High-sensitive radioimmunoassay for human serum hepcidin. Br J Haematol. 2009;1–9
  17. Kulaksiz H, Gehrke SG, Janetzko A, et al. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut. 2004;53:735–743
  18. Ervasti M, Kotisaari S, Heinonen S, Punnonen K. Use of advanced red blood cell and reticulocyte indices improves the accuracy in diagnosing iron deficiency in pregnant women at term. Eur J Haematol. 2007;79:539–545
  19. Ervasti M, Kotisaari S, Sankilampi U, Heinonen S, Punnonen K. The relationship between red blood cell and reticulocyte indices and serum markers of iron status in the cord blood of newborns. Clin Chem Lab Med. 2007;45:1000–1003
  20. Ervasti M, Kotisaari S, Heinonen S, Punnonen K. Elevated serum erythropoietin concentration is associated with coordinated changes in red blood cell and reticulocyte indices of pregnant women at term. Scand J Clin Lab Invest. 2008;68:160–165
  21. Ervasti M, Sankilampi U, Heinonen S, Punnonen K. Novel red cell indices indicating reduced availability of iron are associated with high erythropoietin concentration and low pH level in the venous cord blood of newborns. Pediatr Res. 2008;64:135–140
  22. Ervasti M, Sankilampi U, Heinonen S, Punnonen K. Early signs of maternal iron deficiency do not influence the iron status of the newborn, but are associated with higher infant birthweight. Acta Obstet Gynecol Scand. 2009;88:83–90
  23. Kotisaari S, Romppanen J, Penttilä I, Punnonen K. The Advia 120 red blood cell and reticulocyte indices are useful in diagnosis of iron-deficiency anemia. Eur J Haematol. 2002;68:150–156
  24. WHO . Iron deficiency anaemia. Assessment, prevention, and control. A guide for programme managers. Geneva: WHO; 2001;
  25. Nathan DG, Oski FA. Hematology of infancy and childhood. Philadelphia: Saunders; 1993;
  26. Kotisaari S, Romppanen J, Ågren U, Eskelinen S, Punnonen K. Reticulocyte indices rapidly reflect an increase in iron availability for erythropoiesis. Haematologica. 2003;88:1422–1423
  27. Rao R, Georgieff MK. Iron in fetal and neonatal nutrition. Semin Fetal Neonatal Med. 2007;12:54–63
  28. Chelchowska M, Swiatek E, Ambroszkiewicz J, Gajewska J, Laskowska-Klita T, Leibschang J. Concentrations of pro-hepcidin in serum of pregnant women and in umbilical cord blood. Ginekol Pol. 2008;79:754–757
  29. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA. 2002;99:4596–4601
  30. Balogh Á, Szabó M, Kelen D, Bokodi G. Prohepcidin levels during human perinatal adaptation. Pediatr Hematol Oncol. 2007;24:361–368
  31. Rams L, Drozdowska-Rams L, Malyszko J, Pawlak K, Malyszko J. Prohepcidin in pregnancy: acute phase protein, marker of iron metabolism, or both?. Eur J Obstet Gynecol Reprod Biol. 2008;140:293–294
  32. Roe MA, Spinks C, Heath A-LM, et al. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women. Br J Nutr. 2007;97:544–549
  33. Ulukol B, Orhon FS, Hanoluk A, Akar N. Serum pro-hepcidin levels and relationship with ferritin in healthy non-anaemic infants. Acta Haematol. 2007;118:70–72
  34. Laskowska-Klita T, Chelchowska M, Ambroszkiewicz J, Swiatek E, Leibschang J. Serum pro-hepcidin and iron markers during uncomplicated pregnancy. Eur J Obstet Gynecol Reprod Biol. 2007;130:271–275
  35. Tiker F, Celik B, Tarcan A, Kilicdag H, Özbek N, Gurakan B. Serum pro-hepcidin levels and relationship with iron parameters in healthy preterm and term newborns. Pediatr Hematol Oncol. 2006;23:293–297
  36. Luukkonen S, Punnonen K. Serum pro-hepcidin concentrations and their responses to oral iron supplementation in healthy subjects manifest considerable inter-individual variation. Clin Chem Lab Med. 2006;44:1361–1362

PII: S0301-2115(09)00501-6

doi: 10.1016/j.ejogrb.2009.08.012

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 147, Issue 2 , Pages 161-165 , December 2009

Article Tools

* Image Usage & Resolution